CM
LOXO

Castleark Management’s Loxo Oncology, Inc LOXO Stock Holding History

Castleark Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-32,445
Closed -$5.54M – 417
2018
Q3 		$5.54M Sell
32,445
-1,150
-3% -$193K 0.16% 187
2018
Q2 		$5.83M Buy
+33,595
New +$5.05M 0.18% 177

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Castleark Management's LOXO Position: Q4 2018 in Review

Castleark Management sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 32,445 shares — an estimated $5.54M sold.

Castleark Management first reported a position in LOXO in Q2 2018 and held it in 2 quarters. The position peaked at $5.83M in Q2 2018. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Castleark Management reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Castleark Management sold 32,445 Loxo Oncology, Inc shares in Q4 2018, an estimated $5.54M.
  • Castleark Management first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 2 quarters.
  • Castleark Management's Loxo Oncology, Inc position peaked at $5.83M in Q2 2018.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Castleark Management's 13F filing for Q4 2018, filed 12 Feb 2019.